Cargando…
Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
Assays to measure SARS-CoV-2-specific neutralizing antibodies are important to monitor seroprevalence, to study asymptomatic infections and to reveal (intermediate) hosts. A recently developed assay, the surrogate virus-neutralization test (sVNT) is a quick and commercially available alternative to...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378998/ https://www.ncbi.nlm.nih.gov/pubmed/34458548 http://dx.doi.org/10.1016/j.onehlt.2021.100313 |
_version_ | 1783740918492299264 |
---|---|
author | Embregts, Carmen W.E. Verstrepen, Babs Langermans, Jan A.M. Böszörményi, Kinga P. Sikkema, Reina S. de Vries, Rory D. Hoffmann, Donata Wernike, Kerstin Smit, Lidwien A.M. Zhao, Shan Rockx, Barry Koopmans, Marion P.G. Haagmans, Bart L. Kuiken, Thijs GeurtsvanKessel, Corine H. |
author_facet | Embregts, Carmen W.E. Verstrepen, Babs Langermans, Jan A.M. Böszörményi, Kinga P. Sikkema, Reina S. de Vries, Rory D. Hoffmann, Donata Wernike, Kerstin Smit, Lidwien A.M. Zhao, Shan Rockx, Barry Koopmans, Marion P.G. Haagmans, Bart L. Kuiken, Thijs GeurtsvanKessel, Corine H. |
author_sort | Embregts, Carmen W.E. |
collection | PubMed |
description | Assays to measure SARS-CoV-2-specific neutralizing antibodies are important to monitor seroprevalence, to study asymptomatic infections and to reveal (intermediate) hosts. A recently developed assay, the surrogate virus-neutralization test (sVNT) is a quick and commercially available alternative to the “gold standard” virus neutralization assay using authentic virus, and does not require processing at BSL-3 level. The assay relies on the inhibition of binding of the receptor binding domain (RBD) on the spike (S) protein to human angiotensin-converting enzyme 2 (hACE2) by antibodies present in sera. As the sVNT does not require species- or isotype-specific conjugates, it can be similarly used for antibody detection in human and animal sera. In this study, we used 298 sera from PCR-confirmed COVID-19 patients and 151 sera from patients confirmed with other coronavirus or other (respiratory) infections, to evaluate the performance of the sVNT. To analyze the use of the assay in a One Health setting, we studied the presence of RBD-binding antibodies in 154 sera from nine animal species (cynomolgus and rhesus macaques, ferrets, rabbits, hamsters, cats, cattle, mink and dromedary camels). The sVNT showed a moderate to high sensitivity and a high specificity using sera from confirmed COVID-19 patients (91.3% and 100%, respectively) and animal sera (93.9% and 100%), however it lacked sensitivity to detect low titers. Significant correlations were found between the sVNT outcomes and PRNT(50) and the Wantai total Ig and IgM ELISAs. While species-specific validation will be essential, our results show that the sVNT holds promise in detecting RBD-binding antibodies in multiple species. |
format | Online Article Text |
id | pubmed-8378998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83789982021-08-23 Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test Embregts, Carmen W.E. Verstrepen, Babs Langermans, Jan A.M. Böszörményi, Kinga P. Sikkema, Reina S. de Vries, Rory D. Hoffmann, Donata Wernike, Kerstin Smit, Lidwien A.M. Zhao, Shan Rockx, Barry Koopmans, Marion P.G. Haagmans, Bart L. Kuiken, Thijs GeurtsvanKessel, Corine H. One Health Research Paper Assays to measure SARS-CoV-2-specific neutralizing antibodies are important to monitor seroprevalence, to study asymptomatic infections and to reveal (intermediate) hosts. A recently developed assay, the surrogate virus-neutralization test (sVNT) is a quick and commercially available alternative to the “gold standard” virus neutralization assay using authentic virus, and does not require processing at BSL-3 level. The assay relies on the inhibition of binding of the receptor binding domain (RBD) on the spike (S) protein to human angiotensin-converting enzyme 2 (hACE2) by antibodies present in sera. As the sVNT does not require species- or isotype-specific conjugates, it can be similarly used for antibody detection in human and animal sera. In this study, we used 298 sera from PCR-confirmed COVID-19 patients and 151 sera from patients confirmed with other coronavirus or other (respiratory) infections, to evaluate the performance of the sVNT. To analyze the use of the assay in a One Health setting, we studied the presence of RBD-binding antibodies in 154 sera from nine animal species (cynomolgus and rhesus macaques, ferrets, rabbits, hamsters, cats, cattle, mink and dromedary camels). The sVNT showed a moderate to high sensitivity and a high specificity using sera from confirmed COVID-19 patients (91.3% and 100%, respectively) and animal sera (93.9% and 100%), however it lacked sensitivity to detect low titers. Significant correlations were found between the sVNT outcomes and PRNT(50) and the Wantai total Ig and IgM ELISAs. While species-specific validation will be essential, our results show that the sVNT holds promise in detecting RBD-binding antibodies in multiple species. Elsevier 2021-08-21 /pmc/articles/PMC8378998/ /pubmed/34458548 http://dx.doi.org/10.1016/j.onehlt.2021.100313 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Embregts, Carmen W.E. Verstrepen, Babs Langermans, Jan A.M. Böszörményi, Kinga P. Sikkema, Reina S. de Vries, Rory D. Hoffmann, Donata Wernike, Kerstin Smit, Lidwien A.M. Zhao, Shan Rockx, Barry Koopmans, Marion P.G. Haagmans, Bart L. Kuiken, Thijs GeurtsvanKessel, Corine H. Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test |
title | Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test |
title_full | Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test |
title_fullStr | Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test |
title_full_unstemmed | Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test |
title_short | Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test |
title_sort | evaluation of a multi-species sars-cov-2 surrogate virus neutralization test |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378998/ https://www.ncbi.nlm.nih.gov/pubmed/34458548 http://dx.doi.org/10.1016/j.onehlt.2021.100313 |
work_keys_str_mv | AT embregtscarmenwe evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT verstrepenbabs evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT langermansjanam evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT boszormenyikingap evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT sikkemareinas evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT devriesroryd evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT hoffmanndonata evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT wernikekerstin evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT smitlidwienam evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT zhaoshan evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT rockxbarry evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT koopmansmarionpg evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT haagmansbartl evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT kuikenthijs evaluationofamultispeciessarscov2surrogatevirusneutralizationtest AT geurtsvankesselcorineh evaluationofamultispeciessarscov2surrogatevirusneutralizationtest |